Get started
Roche Holding Ltd Sponsored ADRRoche Holding Ltd Sponsored ADRRoche Holding Ltd Sponsored ADR

Roche Holding Ltd Sponsored ADR

No trades
See on Supercharts
Overview
Financials News Discussions Forecast Seasonals Bonds

RHO6 chart


Full chart

RHO6 upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪230.91 B‬ EUR
Dividend yield (indicated)
2.00%
Price to earnings Ratio (TTM)
24.345
Basic EPS (TTM)
1.455 EUR
Net income (FY)
‪9.08 B‬ EUR
Revenue (FY)
‪66.36 B‬ EUR
Shares float
‪5.52 B‬
Beta (1Y)
0.49

About Roche Holding Ltd


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Thomas Schinecker
Website
roche.com
Headquarters
Basel
Founded
1896
ISIN
US7711951043
FIGI
BBG000C69440
Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics, and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Check out other big names from the same industry as RHO6.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

RHO6 news



Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

RHO6 highest yielding bonds


CHGCY5885609
Roche Holdings, Inc. 4.203% 09-SEP-2029
Yield to maturity
—
Maturity date
Sep 9, 2029
CHGCY4391962
Roche Holdings, Inc. 7.0% 01-MAR-2039
Yield to maturity
—
Maturity date
Mar 1, 2039
CHGCY5698672
Roche Holdings, Inc. FRN 13-NOV-2026
Yield to maturity
—
Maturity date
Nov 13, 2026
A3K88A
Roche Kapitalmarkt AG 2.0% 23-SEP-2032 2022-23.09.32 GUARANTEED
Yield to maturity
—
Maturity date
Sep 23, 2032
CHGCY3666852
Genentech, Inc. 5.25% 15-JUL-2035
Yield to maturity
—
Maturity date
Jul 15, 2035
A3K88B
Roche Kapitalmarkt AG 1.5% 23-JUN-2026 2022-23.06.26 GUARANTEED
Yield to maturity
—
Maturity date
Jun 23, 2026
A3LQ44
Roche Kapitalmarkt AG 1.6% 15-SEP-2028 2023-15.09.28
Yield to maturity
—
Maturity date
Sep 15, 2028
CHGCY5698948
Roche Holdings, Inc. 5.265% 13-NOV-2026
Yield to maturity
—
Maturity date
Nov 13, 2026
CHGCY5885612
Roche Holdings, Inc. 4.592% 09-SEP-2034
Yield to maturity
—
Maturity date
Sep 9, 2034
A3LRKK
Roche Kapitalmarkt AG 1.75% 15-SEP-2033 2023-15.09.33
Yield to maturity
—
Maturity date
Sep 15, 2033
A3LRKJ
Roche Kapitalmarkt AG 1.95% 15-SEP-2038 2023-15.09.38
Yield to maturity
—
Maturity date
Sep 15, 2038

See all RHO6 bonds 

Sparks


Curated watchlists where RHO6 is featured.

See all sparks